GPX4 and gastric cancer: Conversely, in gastric cancer cells harbouring p53 mutations, OTUD5 transcription is upregulated due to the inactivation of p53, allowing OTUD5 to stabilise GPX4 protein, inhibit ferroptosis and thereby promoting gastric cancer progression (Figure 6J, right panel).